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PURPOSE. Mutations in the coding sequence of the L and M opsin genes are often associated
with X-linked cone dysfunction (such as Bornholm Eye Disease, BED), though the exact color
vision phenotype associated with these disorders is variable. We examined individuals with L/
M opsin gene mutations to clarify the link between color vision deficiency and cone
dysfunction.
METHODS. We recruited 17 males for imaging. The thickness and integrity of the
photoreceptor layers were evaluated using spectral-domain optical coherence tomography.
Cone density was measured using high-resolution images of the cone mosaic obtained with
adaptive optics scanning light ophthalmoscopy. The L/M opsin gene array was characterized
in 16 subjects, including at least one subject from each family.
RESULTS. There were six subjects with the LVAVA haplotype encoded by exon 3, seven with
LIAVA, two with the Cys203Arg mutation encoded by exon 4, and two with a novel insertion
in exon 2. Foveal cone structure and retinal thickness was disrupted to a variable degree, even
among related individuals with the same L/M array.
CONCLUSIONS. Our findings provide a direct link between disruption of the cone mosaic and L/
M opsin variants. We hypothesize that, in addition to large phenotypic differences between
different L/M opsin variants, the ratio of expression of first versus downstream genes in the L/
M array contributes to phenotypic diversity. While the L/M opsin mutations underlie the cone
dysfunction in all of the subjects tested, the color vision defect can be caused either by the
same mutation or a gene rearrangement at the same locus.
Keywords: opsin, myopia, adaptive optics, dichromacy, color vision
The cone dysfunction syndromes are a clinically andgenetically heterogeneous group of conditions character-
ized by early-onset reduction in central vision associated with
a variable degree of photophobia and nystagmus, normal
fundus examination, and generalized cone dysfunction with
normal rod function on electroretinography (ERG).1,2 Born-
holm eye disease (BED) is a cone dysfunction syndrome,
having been first reported in a single large Danish family with
high myopia, astigmatism, optic nerve changes, abnormal
cone ERG, and a deutan color vision defect.3,4 Linkage analysis
in the Danish family mapped BED to Xq28, and it became the
first locus identified for high myopia (MYP1, OMIM number
310460). A second MYP1 family of Danish descent, living in
Minnesota, had high myopia like the original Danish family,
although they had an accompanying protan (instead of
deutan) color vision defect.5 Similarly, five families in the
United Kingdom with X-linked cone dysfunction and protan-
opia were reported in 2005.6 Four additional families with X-
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linked high myopia, of Chinese7,8 and Asian Indian origin,9
also have been mapped to MYP1; however, affected members
all had normal color vision. Thus, the emerging picture for
BED is that no single color vision phenotype is a consistent
feature of the disorder.
Xq28 (the locus of MYP1) encompasses the long- and
middle-wavelength sensitive opsin gene array (OPN1LW and
OPN1MW, or L and M, respectively). The initial studies of the
Danish, Minnesota, and UK families identified common gene
rearrangements within the opsin gene array accounting for the
color vision defects, though no mutations were identified to
account for the cone dysfunction.5,6,10 However, there is
evidence that mutations in the L/M opsin coding sequence can
disrupt cone structure/function.11 For example, a specific
combination of polymorphisms encoded by exon 3 of the L
and M pigment genes (Leu153, Ile171, Ala174, Val178, Ala180
¼ LIAVA) was found to result in the loss of function of an entire
class of cone photoreceptor; leading to dichromacy when
occurring in either the L or the M gene,12–14 or blue cone
monochromacy (BCM) when occurring in all of the expressed
L/M genes.15,16 However, the dichromatic individuals with the
LIAVA haplotype were not noted to show other features
initially associated with BED (e.g., cone dysfunction and high
myopia).12,13 Moreover, in contrast to the variable color vision
phenotype of the aforementioned MYP1 BED families, the
color vision phenotype in these individuals correlates perfectly
with genotype; that is, LIAVA encoded by an L gene in the
presence of normal M gene(s) results in protanopia, LIAVA
encoded by an M gene in the presence of a normal L gene
results in deuteranopia, and individuals with LIAVA encoded by
all expressed L/M genes (i.e., at least the first two genes in the
array) have BCM.
The Danish and Minnesota BED families had another unique
combination of amino acids encoded by exon 3 (Leu153,
Val171, Ala174, Val178, Ala180¼LVAVA) in one gene of their L/
M opsin arrays.17 However, the Minnesota family had three
genes encoding M pigments (conferring an obligate protan
phenotype), with LVAVA encoded by exon 3 of the first gene in
the array. In contrast, the first two genes in the array of the
Danish family encoded L pigments with a spectral separation of
2.5 nm (conferring an obligate deuteranomalous phenotype),
with LVAVA encoded by exon 3 of the first gene in the array.
The LVAVA haplotype also cosegregated with high myopia in
the MYP1 Chinese families.8 It has been shown that LIAVA,
LVAVA, and related variants are associated with aberrant
splicing,18,19 in which exon 3 is skipped and exon 2 is spliced
to exon 4, introducing a frame shift and a premature stop
codon. In an in vitro assay, virtually all the mRNA from the
LIAVA mutant was missing exon 3, explaining the complete
loss of function of that pigment.18,19 However, in the same
assay, a small but significant fraction of mRNA from the LVAVA
mutant is normally spliced, presumably allowing the produc-
tion of a reduced amount of LVAVA opsin. Thus, cones
expressing this variant should have residual function, which
is consistent with the observation of normal color vision in the
Chinese LVAVA MYP1 families.7,8
It is becoming appreciated that different OPN1LW/
OPN1MW mutations have distinctly different effects on
cone function and viability.13,16,20–23 For example, we
reported on two single-gene dichromats with LVAVA encod-
ed by exon 3 of their only L/M opsin gene.21 They had a late-
onset progressive phenotype in direct contrast to individuals
harboring the missense mutation Cys203Arg, which has
been shown to lead not only to loss of function,24–26 but also
very early degeneration of cones, resulting in reorganization
into a regularly packed, albeit sparser, cone mosaic as
imaged with adaptive optics ophthalmoscopy.20 There are
also differences within genotypes – LIAVA and Cys203Arg
often have been associated with dichromatic color vi-
sion,12,13,20,27 but only recently have been reported in
families diagnosed as having BED.17 Moreover, unlike LIAVA,
the LVAVA haplotype has not been reported in individuals
with simple dichromacy. In an effort to better characterize
the genotype–phenotype relationship in X-linked cone
dysfunction, we used quantitative retinal imaging, optical
coherence tomography (OCT) and adaptive optics scanning
light ophthalmoscopy (AOSLO), to examine 17 males with a
diagnosis of BED, including two subjects from the original
Danish family and four subjects from the original Minnesota
family. We observed variable disruption of the cone mosaic
across subjects, with the degree of disruption correlating
with axial length. While the opsin variant (e.g., LIAVA,
LVAVA, Cys203Arg) appears to be the main determinant of
phenotypic differences across subjects, the degree of
generalized cone dysfunction and high myopia may also
depend on the relative number of cones expressing the
aberrant pigment. It has been shown that the relative
number of L and M cones (L:M ratio) varies greatly across
individuals.28,29 Thus, we propose that genes or sequences
that modulate L:M cone ratio in color normal individuals30,31
may be involved in determining the final phenotype in
individuals with these opsin variants.1
METHODS
Subjects
This study followed the tenets of the Declaration of Helsinki
and was approved by local Institutional Review Boards.
Informed consent was obtained from all subjects, after the
nature and possible consequences of the study were explained.
We examined 17 patients; the clinical phenotype of 13 of these
subjects has been described previously in detail.4–6,13 Although
one subject (MM_0145) was not genetically sequenced, the
similarity in phenotype between him and his brother
(MM_0144) allows his genotype to be reasonably inferred.
The four new subjects each provided a blood sample, from
which DNA was isolated. The opsin genes were amplified and
sequenced using previously described methods to determine
the type of mutation, as well as its position within the gene
array.12,20 Axial length was measured in each eye imaged using
the Zeiss IOL Master (Carl Zeiss Meditec, Dublin, California,
USA). Color vision for the 4 newly recruited subjects was
assessed using the American Optical Hardy-Rand-Rittler (AO-
HRR) and the anomaloscope when available. A brief summary
of genetic and clinical findings is provided in Table 1.
Adaptive Optics Retinal Imaging
Images of the central photoreceptor mosaic were obtained
with one of two previously described confocal AOSLO systems,
housed either at the Medical College of Wisconsin or at
Moorfields Eye Hospital, London.32–36 Eyes were dilated using
one drop each of phenylephrine hydrochloride (2.5%) and
tropicamide (1%) before imaging. Images were typically
collected at different locations across the central fovea, as
well as in strips, up to 108 from fixation in the temporal and
superior directions.
Because the system acquires images by scanning the
retina, there are distortions inherent to the raw videos that
must be removed. Sinusoidal distortions were measured and
corrected for using a Ronchi ruling of known spacing. From
the resampled image sequences, a set of minimally-distorted
frames, judged visually, were selected as references to which
all other frames within that sequence would be registered
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and averaged using previously described strip-based registra-
tion software.37 The resultant images were stitched together
manually in Photoshop (Adobe Photoshop; Adobe Systems,
Inc., San Jose, CA, USA) to produce a larger montage for each
of the subjects. Montages were scaled by first determining
the degrees per pixel in an image of a ruling with known
spacing using the small angle approximation. This value was
linearly scaled using the subject’s axial length and a
reference axial length of 24 mm, and multiplied by the
retinal magnification factor, 291 lm/deg, to obtain a final
lm/px scale.
Based on differences in image quality, it was necessary to
use two methods to estimate the location of the fovea, from
which subsequent regions of interest were selected for
density analyses. For seven subjects, cones were identified
over a large area that reliably encompassed the foveal region
using a previously described semiautomated algorithm.38
Next, we used a custom MatLab program to measure cone
density at each pixel in the image using each of 10 sampling
windows ranging in size from 253 25 to 453 45 lm. The 10
densities for each pixel were averaged to create an average
density map, and the location of peak density in this average
density map was used as the location of peak density.39 In
nine subjects, peak cone density was not a reliable indicator
of foveal location; either due to an extremely sparse foveal
cone mosaic or poor image quality resulting in the inability to
resolve foveal cones over a sufficiently large area for the
topographic mapping method. For nine of these subjects the
foveal center was approximated using the preferred retinal
locus, identified as follows: Subjects were asked to fixate on
the center of a square and each corner in turn; the mean of
the coordinates for the center of each frame at each location
was taken as the center of fixation. Visual inspection of the
montages revealed that the resultant coordinates correlated
well with the foveal center. Regions of interest subtending 55
3 55 lm were cropped from the larger montage at the fovea
(when possible) and 0.25, 0.5, 1, 2, and 58 along the temporal
and superior meridia. Within these regions of interest, cones
were identified using a semi-automated algorithm to provide
estimates of cone density.20,38 The image quality for JC_10340
was too poor to enable quantitative analysis.
Spectral-Domain OCT (SD-OCT)
For 15 subjects, high-resolution SD-OCT images of the macula
were acquired using the Bioptigen SD-OCT system (Morris-
ville, NC, USA). High-density line scans (either 750 or 1000 A-
scans/B-scan, 100-120 repeated B scans) were acquired
through the foveal center. Line scans were registered and
averaged to reduce speckle noise in the image as previously
described.40 In addition, volumetric images of the macula and
cross-sectional line scans through the fovea were obtained
using a Zeiss Cirrus HD-OCT (Carl Zeiss Meditec, Dublin,
California, USA) and used for analysis when Bioptigen images
were unavailable (JC_0432 and JC_0433). Volumes were
nominally 6 3 6 mm and consisted of 128 B-scans (512 A-
scans/B-scan).
The lateral scale of each subjects’ OCT data set was
determined by dividing the nominal scan length by the
assumed axial length (24 mm for the Bioptigen; 24.46 mm
for the Cirrus) and multiplying by their measured axial length.
Optical coherence tomography images were assessed in terms
of total retinal thickness, as well as inner retinal thickness
(defined as the distance between the internal limiting
membrane [ILM] and the outer plexiform layer/outer nuclear
layer [OPL/ONL] junction), and the ONL þ Henle Fiber Layer
(HFL) thickness (defined as the distance between the OPL/
ONL junction and the external limiting membrane [ELM]). As
described previously,41 segmentation was done by manually
delineating the boundaries of the ILM, OPL, ONL, and RPE –
choroid junction (RPE2) using ImageJ42 and custom Matlab
software. We then compared our measurements against a
subset of a previously published normative database,43
TABLE 1. A Summary of the Genotype and Clinical Phenotype of Subjects With X-Linked Cone Dysfunction
Subject Age, y Phenotype Genotype
Axial
Length, mm
Spherical
Refraction, D Visual Acuity
SourceOD OS OD OS OD OS
F1* JC_0447 17 Protanope MLVAVA - M - M 26.54 26.52 9.75 9.00 20/20 20/25 Subject 355
F1* JC_0448 14 Protanope MLVAVA - M - M 27.75 27.51 11.50 10.75 20/30 20/25 Subject 365
F1* JC_0451 12 Protanope MLVAVA - M - M 28.10 27.60 9.50 9.00 20/30 20/20 Subject 375
F1† JC_10340 32 Protanope MLVAVA - M - M 28.96 28.08 17.50 13.00 20/20 20/20 Subject 315
F2† JC_0683 36 Deuteranomalous‡ LLVAVA - L - M - M 27.03 26.70 8.50 8.50 20/15 20/15 Subject 864
F2† JC_0758 33 Deuteranomalous‡ LLVAVA - L - M - M 29.18 28.53 12.75 10.00 20/50 20/60 Subject 764
F3 JC_0084 34 Deuteranope L - MLIAVA 25.34 25.19 2.5 2.5 20/20 20/15 Subject NC13
F4* JC_0195 29 Protanope LLIAVA - M - M 27.48 27.32 11.50 12.00 20/60 20/60 Subject B16
F4* JC_0196 28 Protanope LLIAVA - M - M 22.89 22.88 6.00 5.00 20/40 20/40 Subject B26
F5 JC_0609 15 Protanope LLIAVA - M 29.03 29.08 14.00 13.75 20/20 20/20 This study
F6 MM_0142 13 Protanope LLIAVA - M 23.28 23.23 2.00 2.00 20/20 20/20 This study
F7* MM_0144 19 Protanope MLIAVA - M 27.09 26.78 8.00 8.25 20/70 20/40 Subject C16
F7* MM_0145 15 Protanope MLIAVA - M§ 23.52 23.59 plano plano 20/20 20/30 Subject C2
6
F8* JC_0432 23 Protanope LCys203Arg - M - M 27.73 27.82 13.00 12.50 20/40 20/40 Subject A16
F8* JC_0433 16 Protanope LCys203Arg - M - M 26.50 26.27 7.00 7.00 20/60 20/60 Subject A26
F9* MM_0156 12 Protanope LX 2 ins. - M 27.83 28.08 12.50 15.00 20/60 20/50 This study
F9* MM_0157 17 Protanope LX 2 ins. - M 23.71 23.59 plano plano 20/40 20/20 This study
* The following subjects are brothers: JC_0195 and JC_0196; JC_0432 and JC_0433; JC_0447, JC_0448, and JC_0451; MM_0144 and MM_0145;
MM_0156 and MM_0157.
† JC_10340 is a cousin of JC_0447, JC_0448; and JC_0451. JC_0683, and JC_0758 are cousins.
‡ Estimated spectral separation of the pigments encoded by the first two genes in the array is 2.5 nm. Rayleigh match ranges were 0 to 65 for
JC_0683 and 0 to 59 for JC_0758.
§ MM_0145 was not genetically sequenced; genotype was inferred from brother (MM_0144).
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consisting of 70 males, with an average age of 30.7 6 30 years
(range, 7–60 years).
RESULTS
Clinical Phenotype Varies Across Subjects With
OPN1LW/OPN1MW Mutations
A summary of the genotype and clinical phenotype for each
patient is given in Table 1. Six subjects harbored the LVAVA
haplotype, seven had the LIAVA haplotype, and two had the
Cys203Arg missense mutation. One family had a novel
insertion in exon 2 of their L gene: following nucleotide
position 179 in exon 2 (where the first base of exon 2 is
position #1) there is a 32-base pair (bp) insertion that
corresponds exactly in sequence to nucleotides 149 to 179
of exon 2, thereby creating a direct repeat of 32 bp within the
exon. The insertion shifts the protein reading frame and
introduces multiple termination codons. Thus, it is likely that
the mRNA, if produced, is degraded through one of the many
mRNA decay pathways.44 The exact mechanism by which the
insertion disrupts cone function is unknown, but possible
mechanisms include creating a new RNA secondary structure,
altering the protein coding sequence, or altering splicing.
Genes encoding the LIAVA, Cys203Arg, and exon 2
insertion all would be associated with a lack of function for
cones expressing those genes; thus, the gene arrays of
JC_0084, JC_0195, JC_0196, JC_0609, MM_0142, MM_0144,
MM_0145, JC_0432, JC_0433, MM_0156, and MM_0157 all
confer an obligate dichromatic phenotype. In contrast, the
deutan subjects (JC_0683 and JC_0758) with LLVAVA have the
genetic basis for anomalous trichromacy, assuming that their
LVAVA-expressing cones retain some function. Subjects from
the Minnesota family (JC_0447, JC_0448, JC_0451, and
JC_10340) harboring MLVAVA have the genetic basis for either
dichromacy or anomalous trichromacy depending on whether
their first two genes encode spectrally different pigments.
They have three gene-encoding M pigments and the basis for
two spectral types, but whether the first two genes specify
spectrally different pigments was not determined from the
analysis. Across all subjects, axial length (mean 6 SD) was on
average greater than normal (26.49 6 4.02 vs. 24.00 6 1.09
mm).45 Interestingly, the LVAVA subjects had significantly
longer axial lengths on average compared to the subjects with
the LIAVA haplotype (27.9 vs. 25.5 mm; P¼ 0.044, unpaired t-
test). The LVAVA subjects were more myopic on average than
the LIAVA subjects (11.6 vs.6.2 diopters [D]); however, this
was not statistically significant (P ¼ 0.054, unpaired t-test).
Although high myopia often is associated with the mutant
opsins studied here, there was a 9 D range in refractive error
among the LVAVA subjects and a 14 D range in refractive error
among the LIAVA subjects (with one even being emmetropic).
Retinal Lamination
Although retinal thickness was generally reduced across the
horizontal meridian, large differences in retinal thickness and
lamination integrity were identified between different geno-
type groups (Fig. 1). Total retinal thickness at the fovea ranged
from 142.70 to 212.56 lm with a mean of 181.42 6 21.25 lm,
compared to that of normal male controls who had a mean
foveal thickness of 216.08 6 38.91 lm (Fig. 2A). However,
retinal thinning has been associated with myopia,46–48 and our
controls had a mean axial length of 24.17 mm; thus, it is
FIGURE 1. Variable disruption in retinal lamination in X-linked cone dysfunction. Shown are high-resolution SD-OCT images (horizontal line scans)
through the fovea. One image from each family is displayed, labeled with the subject ID and corresponding genotype. There is clear variability in
ONL thickness across subjects, with MM_0142 and JC_0433 having the most pronounced ONL thinning at the fovea. Variation in foveal morphology
also is apparent, which has been reported previously.64 The integrity of the second (IS/OS or EZ) and third (IZ) hyperreflective bands was variable
across subjects, ranging from normal to mottled in appearance. Scale bar: 200 lm.
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difficult to disambiguate retinal thinning due to possible loss of
photoreceptors from that owing to axial elongation of the eye.
Regardless, there was no apparent correlation between axial
length and foveal thickness (R2 ¼ 0.1025, P ¼ 0.21). Subjects
with the Cys203Arg mutation and the LIAVA haplotype had the
greatest reduction in retinal thickness at the fovea, while
thickness for subjects harboring the exon 2 insertion and
LVAVA was within the normal range at the fovea. Further
examination revealed reduced ONL þ HFL thickness (Fig. 2C)
but relatively normal inner retinal thickness (Fig. 2B) in all
subjects; thus, the overall reduction in retinal thickness can be
attributed primarily to ONL þ HFL thinning; with the
Cys203Arg mutation and LIAVA haplotype being associated
with the greatest degree of outer retinal thinning (Fig. 2C). The
appearance of the outer hyperreflective bands was highly
variable. For example, in some subjects (JC_0758, MM_0145,
and JC_0433) there appear to be irregularities in the third
hyperreflective band (interdigitation zone [IZ]49,50), similar to
those seen in patients with oligocone trichromacy (Fig. 1).43
Two subjects had no clearly resolvable IZ band (JC_0195 and
JC_0609), while the rest generally had a normal-appearing IZ
(JC_0451, JC_0084, MM_0142, JC_0433, and MM_0157) (Fig.
1). In addition, subjects JC_0609 and JC_0758 showed
‘‘mottling’’ of the second hyperreflective band (ellipsoid zone
[EZ]49,50), whereas the remaining subjects had a qualitatively
intact EZ band (Fig. 1).
Variable Disruption of the Cone Mosaic in X-
Linked Cone Dysfunction
All patients had significantly disrupted cone mosaics, with a
high degree of intersubject variability (Fig. 3). Cone density
was reduced compared to normal,51 at all locations in all
subjects, as shown in Table 2. For reference, a normal age-
matched retina with a peak cone density of 195,030 cones/
mm2 is shown in the top left panel of Figure 3.52
Various studies have reported peak foveal cone density to
range from approximately 85,000 to nearly 250,000 cones/
mm2 in normal subjects.39,53,54 In our subjects, the cone
mosaic was discontiguous and of variably reduced density,
ranging from 18,129 to 100,069 cones/mm2 at the fovea.
These findings indicate that in subjects with the opsin
sequence variants studied here, cone density and topography
are significantly disrupted. There are, however, striking
differences in the degree of mosaic disruption, not only
between subjects who have similar genotypes, but also
between related individuals having the same L/M gene array
(Table 1, Fig. 4).
Regression analysis of the relationship between foveal cone
density and the severity of myopia revealed a strong correlation
(R2 ¼ 0.46, P < 0.01). As might be expected, given the
relatedness between myopia and axial length, there also was a
significant inverse relationship between cone density and axial
length (R2 ¼ 0.47, P < 0.01), even after correcting for lateral
magnification. The relationship between foveal cone density
and ONL thickness, on the other hand, was not statistically
significant (R2 < 0.01, P ¼ 0.80), in contrast to findings in
normal eyes.55 Furthermore, differences in cone density were
not apparent functionally, as demonstrated by a null relation-
ship with visual acuity (R2 ¼ 0.15, P ¼ 0.17).
FIGURE 2. Subjects with X-linked cone dysfunction show reduced
outer retinal thickness compared to normals. Plotted are the mean SD-
OCT retinal thickness measurements along the horizontal meridian for
each group of mutations. (A) Total retinal thickness, (B) inner retinal
thickness, (C) ONL þ HFL thickness. Solid black lines represent the
mean values for 70 normal male controls, with the shaded region
representing 6 2 SD from the mean. Filled squares represent the six
individuals with the LVAVA haplotype (JC_0447, JC_0448, JC_0451,
JC_0683, JC_0758, and JC_10340). Filled circles represent the averaged
data from the seven individuals with the LIAVA haplotype (JC_0084,
JC_0195, JC_0196, JC_0609, MM_0142, MM_0144, and MM_0145).
Open triangles represent the two brothers with Cys203Arg mutations
(JC_0432 and JC_0433). Open diamonds represent the two brothers
with the novel exon 2 insertion (MM_0156 and MM_0157).
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DISCUSSION
In this study, we performed quantitative high-resolution retinal
imaging to probe the structural effects of LVAVA, LIAVA,
Cys203Arg, and exon insertion variants. In all patients in our
series, reduced cone density and reduced ONL thickness was
observed, albeit to variable degrees, between and within
families. The imaging data here provided a direct link between
the retinal mosaic (secondary to the LVAVA/LIAVA/ Cys203Arg/
exon insertion variants)12,13,20 and the cone dysfunction, as
well as the color vision defect for patients who have otherwise
normal L/M array structure (a single L gene followed by one or
more M genes).
Cause of Red-Green Color Vision Defects in
Patients With X-Linked Cone Dysfunction
An important aspect of the present work is that many patients
with X-linked cone dysfunction (previously referred to as BED)
can have multiple alterations present within the L/M gene
array, although not all of these alterations necessarily cause a
color vision defect. The LIAVA opsin gene variant is associated
with absence of function of the corresponding cone. Thus, the
color vision deficiency is directly attributable to the absence of
function of the cone type corresponding to the opsin gene
encoding the LIAVA variant in these subjects (JC_0084,
JC_0195, JC_0196, and JC_0609, MM_0142, MM_0144,
MM_0145). The protan color vision defect in JC_0432 and
JC_0433 is attributable to the presence of the inactivating
Cys203Arg mutation in the L cone photopigment (leaving only
functional M photopigment). Likewise the protan phenotype
of subjects MM_0144 (and MM_0145 by inference) is due to
the 32 bp insertion in exon 2 of the L gene, meaning only
functional M photopigment is predicted in these retinas. For
subjects JC_0447, JC_0448, JC_0451, and JC_10340 (from the
original MLVAVA Minnesota family) the protan color vision
deficiency can be accounted for by the presence of only M
opsin genes in the L/M gene array for each subject. For subjects
JC_0683 and JC_0758 (from the original LLVAVA Danish family),
their reported deutan color vision defect is attributed to L
genes being the first two in the array, which encode pigments
with a spectral separation of 2.5 nm. In keeping with this,
these subjects had Rayleigh match ranges consistent with
deuteranomalous trichromacy, not deuteranopia as originally
reported in the first descriptions of the family. This, coupled
with the normal color vision in the Chinese MYP1 BED
FIGURE 3. Photoreceptor mosaic disruption is highly variable in X-linked cone dysfunction, even within a given genotype. Foveal AOSLO images are
shown for three subjects with the LIAVA haplotype and, for comparison, a previously published normal control with a peak density of 195,030
cones/mm2 (JC_0138).39 Although many dark spaces are visible in JC_0084’s mosaic, there is tight packing at the fovea (peak density ¼ 100,069
cones/mm2). In contrast, MM_0142 has fewer dark spaces but a more loosely packed mosaic (peak density¼ 53,356 cones/mm2). Subject JC_0609
shows the greatest degree of disruption, with many dark areas, resulting in a much sparser cone mosaic (peak density¼ 18,927 cones/mm2). Scale
bar: 50 lm.
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families,7,8 is direct evidence that the LVAVA variant is
functional, at least to some extent.
The original clinical classification of BED included high
myopia, dichromacy, astigmatism, optic nerve changes, and
abnormal cone ERG. Presumably, what called attention to the
original BED family was the fact that the high myopia was
associated with the color vision defect, subsequently inspiring
the linkage studies and the identification of the MYP1 locus.
However, as previously suggested1,17 and as shown here, the
LVAVA mutation causing the cone dysfunction is simply closely
linked to L/M gene rearrangements causing the color defect,
and so the two cosegregated. Importantly, while all the
pathologic features of BED, including cone dysfunction, the
high myopia, and abnormal ERG, are directly caused by LVAVA,
the color vision defect is not caused by LVAVA. This is
consistent with the observation of normal color vision in the
Asian Indian families who were mapped toMYP1 as well as the
Chinese families who were mapped toMYP1,7 and later shown
to harbor LVAVA.8 As approximately 8% of males are color-
deficient, we estimate that for every colorblind BED patient
with LVAVA, there are likely at least 10 times as many color-
normal males with many or all of the same pathologic
symptoms seen in BED. However, this is based on the
assumption that the LVAVA variant occurs with equal frequency
in color-normal and color-deficient populations. Nevertheless,
genetic testing is important for identifying LVAVA patients,
most of whom have normal color vision and will rarely be
associated with a color vision defect. However LVAVA can lead
to severe localized degeneration;21 thus, there may be
subclinical changes in the retinas of these individuals – it
would be interesting to image these color normal individuals
with AOSLO and examine the integrity of their photoreceptor
mosaic.
Phenotypic Variation and L:M Cone Ratio
There were marked differences in phenotype with regard to
the severity of cone mosaic disruption across subjects, even in
individuals harboring the same OPN1LW/OPN1MW mutations.
We hypothesize that individual differences in the relative
expression of first versus downstream genes in the L/M array
(which modulates L:M cone ratio in color normal individuals)
may underlie this variability.1 Already, large individual differ-
ences have been demonstrated in L:M cone ratio in normal
subjects, ranging from 28% to 93% L, corresponding to more
than a 30-fold range in L:M ratio (0.4–13).28,29 For example,
mutations causing loss of function or viability of the cones
expressing that pigment (e.g., LIAVA and Cys203Arg), could
result in dramatically different phenotypes based on how many
cones express the mutant pigment. If only 10% to 30% of the
cones are lost or nonfunctional, perhaps none of the other
symptoms of BED may be observed. Conversely, the situation
may be quite different if 70% to 90% of the cones are lost or
nonfunctional as a result of the same mutations; in these cases,
many more of the BED-like symptoms, including myopia and
abnormal ERG, may be observed. Whereas extreme L:M cone
ratios may be relatively rare in normal individuals, the ability of
the LIAVA or Cys203Arg mutation to reside in either the first or
second gene in the L/M array would result in a higher
incidence of skewed ratios of normal:mutant gene expression.
Cone ratio may also modulate the severity of symptoms for
subjects with the LVAVA haplotype, although the effect of this
haplotype appears generally to be more severe, such that most
subjects, even those expressing LVAVA in a minority cone
population, may exhibit BED symptoms, particularly later in
life if there is a progressive loss of cones due to possible
bystander effects.21 In the subjects studied here, greater
severity of the LVAVA mutation is evident in the significantly
higher axial length and slightly higher myopia among LVAVA
patients compared to LIAVA, though interestingly there was
not a concomitant difference in retinal thickness. It currently
appears that the vast majority of people with the LVAVA
haplotype do not have a color vision defect, so they would not
be diagnosed as having BED, despite suffering from high
myopia and cone dysfunction characteristic of BED.
Interestingly, there was a high degree of variation in the
cone mosaic within each set of brothers, despite them having
the same opsin gene array in each case; this also was associated
with pronounced differences in visual acuity and refractive
TABLE 2. Cone Density for Subjects With X-Linked Cone Dysfunction
Subject* Mutation Fovea 0.258 T 0.258 S 0.58 T 0.58 S 18 T 18 S 28 T 28 S 58 T 58 S
JC_0447 MLVAVA 44,048 56,987 12,910 45,164 22,760 _ _ _ _ _ _
JC_0448 MLVAVA 44,409 39,345 39,825 25,253 19,318 18,006 14,675 _ _ _ _
JC_0451 MLVAVA _ 43,413 _ 38,777 22,466 25,917 23,444 _ _ _ _
JC_10340 MLVAVA _ _ _ _ _ _ _ _ _ _ _
JC_0683 LLVAVA 43,983 29,496 51,239 26,741 28,954 21,052 _ _ _ _ _
JC_0758 LLVAVA _ _ _ 15,892 20,273 13,518 10,872 _ 2321 _ _
JC_0084 MLIAVA 100,069 78,491 43,299 50,544 32,085 33,096 23,021 20,347 9132 _ _
JC_0195 LLIAVA 31,986 21,819 16,293 16,808 11,760 10,903 9705 4086 9165 3399 _
JC_0196 LLIAVA 79,612 74,582 58,233 49,605 44,539 33,067 37,355 23,376 14,140 _ 9010
JC_0609 LLIAVA 18,927 18,586 14,900 10,313 6627 10,554 10,250 _ _ 4928 4842
MM_0142 LLIAVA 53,356 46,540 37,851 34,353 30,183 26,517 12,742 16,002 8817 5074 5297
MM_0144 MLIAVA 22,781 26,156 22,489 27,981 21,360 _ 14,840 _ _ _ _
MM_0145 MLIAVA 54,713 45,834 41,183 32,634 29,131 15,013 11,706 10,387 _ 9957 5460
JC_0432 LCys203Arg 23,457 15,571 19,784 25,363 15,357 16,050 10,185 _ _ _ _
JC_0433 LCys203Arg 26,775 27,038 25,763 23,816 21,045 18,003 13,163 _ _ _ _
MM_0156 LX 2 ins. 18,129 27,184 21,717 14,757 10,927 15,345 9196 8522 8874 _ _
MM_0157 LX 2 ins. 67,739 60,107 45,482 41,368 32,027 27,786 18,298 14,980 7536 _ _
Mean 44,999 40,743 32,212 29,961 23,051 20,345 15,675 13,957 8569 5840 6152
SD 24,456 19,768 14,767 12,539 9588 7666 7765 6764 3463 2848 1923
Mean normal† 119,000 111,600 107,100 90,700 83,800 61,800 54,200 39,000 27,000 15,900 13,370
SD normal† 11,650 10,800 8290 6500 6800 4230 4400 2860 2370 720 750
* All values in cones/mm2.
† Interpolated values derived from data collected by Cooper et al.51
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FIGURE 4. Marked differences in cone mosaic disruption between brothers with X-linked cone dysfunction and OPN1LW/OPN1MW mutations.
Foveal AOSLO images are shown from four pairs of brothers. Large variation, not only in the number of cones, but also their apparent size and
topography, is evident between JC_0195 and JC_0196, and MM_0156 and MM_0157. For example, MM_0157 shows relatively normal topography,
with cone density peaking at the fovea and decreasing with eccentricity (Table 2); MM_0156, on the other hand, has greater disruption at the fovea,
with a large area of low reflectivity surrounded by a sparse mosaic of cones. Scale bar: 100 lm.
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error/axial length within sibling pairs. One possible explana-
tion for this is that the percentage of L cones has been found to
differ by up to 14% among pairs of trichromatic brothers who
share the same L/M gene array (see Supplementary Material).
Even small differences in L:M cone ratio could lead to
significant structural differences. For example, consider two
brothers with L cones expressing one of the mutations
described herein, with one having an L:M ratio of 90% L and
the other of 76% L – this would result in a 2.4-fold difference in
the actual number of functional M cones in their retinas.
In addition to the variability in retinal structure, we also
found a large range in axial length across our sample, with
longer eyes being associated with lower cone density. Although
this trend is in agreement with previous AO literature in the
case of the diseased retina,56–58 the relationship between axial
length and cone density cannot be attributed to retinal
stretching alone. Whereas myopia was considered previously
to be one of the defining characteristics of BED,1,3–5 many of
our subjects were not myopic, having little or no refractive
error while still having mosaic disruption; though this was
observed in LIAVA, but not LVAVA, subjects.
Progressive/Stationary Nature of X-Linked Cone
Dysfunction
Another important factor to consider is whether intrafamilial
differences could be due to disease progression. Not only the
type of mutation but also its position in the gene array could
have important implications for the extent and timing of cone
degeneration. For example, the LIAVA haplotype and the
Cys203Arg missense mutation have been associated with static
mosaic disruption,20,59 whereas the LVAVA haplotype has been
associated with later onset disease progression in those who
possess a single opsin gene.21 Comparison of cone density
values across all subjects revealed no significant correlation
with age at the time of imaging; however, any differences in
cone mosaic integrity and stability between genotypes could
conceal age-related effects in our sample. Nevertheless,
longitudinal assessment is needed before we can rule out the
possibility of progression in these conditions. Moreover, it is
not known whether the dark gaps in the mosaics of our
subjects indicate complete degeneration of the photoreceptors
or whether there is residual cone structure. In some other
retinal conditions, nonconfocal split-detection imaging has
revealed remnant inner-segment structure within dark spaces
similar to those shown here35,60 (Langlo CS, et al. IOVS
2015;56:ARVO E-Abstract 4017). This indicates that a lack of
reflectivity in confocal AOSLO images is not necessarily
indicative of complete cone degeneration. This is important,
as mosaic disruption similar to that of our subjects has been
reported in a number of other retinal conditions.61–63
Longitudinal examination using nonconfocal split-detection
imaging is needed to determine the relative stability of the
photoreceptor mosaic across the different genotypes reported
here, and arguably to better determine the potential for future
therapeutic intervention by identifying cones that could be
rescued with gene replacement or other therapies.
CONCLUSIONS
Our assessment of subjects with mutations in the coding
region of OPN1LW/OPN1MW revealed significantly disrupted
foveal cone mosaics and reduced retinal thickness. There was a
large degree of variation in the number and spacing of
photoreceptors, even within families with the same L/M array,
which is most likely due to variability in the genetic
mechanisms that control L:M cone ratio in color-normal
individuals. Our results suggested that mutations that com-
pletely disrupt cone function, either by causing early cone cell
death (Cys203Arg) or a complete loss of cone function (LIAVA),
lead to dichromacy, but not necessarily high myopia and other
cone dysfunction symptoms seen in the LVAVA BED patients.
Defects caused by such mutations may be more common than
previously thought, and their effects on structure and function
of cones is yet to be fully appreciated. Investigation of other
exon 3 haplotypes combined with systematic comparison with
a normative database is needed to fully understand the effects
of genotype. Future work using additional measurement
techniques, such as more extensive color vision testing and
split-detection AOSLO imaging,35 may enable us to establish
possible genotype/phenotype correlations in the broad spec-
trum of disorders associated with OPN1LW/OPN1MW muta-
tions. However, as no single color vision phenotype is a
consistent feature of patients withMYP1 BED, we propose that
color vision deficiency be removed as a necessary feature of
this condition.
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